Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trial-Reference-Cited by-同舟云学术

Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trial

Published:2021-12 Issue:6 Volume:6 Page:100318
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Assenat E.,de la Fouchardière C.,Portales F.,Ychou M.,Debourdeau A.,Desseigne F.,Iltache S.,Fiess C.,Mollevi C.,Mazard T.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res,2014

2. More deaths from pancreatic cancer than breast cancer in the EU by 2017;Ferlay;Acta Oncol Stockh Swed,2016

3. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Ducreux;Ann Oncol,2015

4. Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study;Huang;BMC Med,2018

5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Chemotherapeutic Regimens Used in Pancreatic Cancer;Cureus;2023-10-07

2. Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine;Cancers;2023-01-08

3. Comprehensive bioinformatics analysis reveals the significance of forkhead box family members in pancreatic adenocarcinoma;Aging;2023-01-04

4. Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis;Diagnostics;2022-11-25

5. Comprehensive analysis of the effects of KIF2C on prognosis, biological functions and immune infiltration in PAAD;Tissue and Cell;2022-10